Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Gemini Space Station Rises, Oracle Slumps, Eli Lilly Rises on Experimental Shot Cutting Weight |...
Posted
December 11, 2025
Views
211
Likes
1
Engagement
0.47%
December 11, 2025
211
1
0.47%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:13Now PlayingOn this episode of Stock Movers:
- Gemini Space Station (GEMI) shares rise after the crypto exchange founded by the Winklevoss twins said it received a Designated Contract Market license from the Commodity Futures Trading Commission, allowing Gemini to offer prediction markets in the US.
- Oracle (ORCL) Shares slump after the company forecast 3Q cloud sales growth below analyst estimates, raising concerns that supply constraints are preventing the cloud infrastructure provider from converting its large backlog to actual revenues.
- Eli Lilly (LLY) shares rise after a next-generation obesity shot helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Gemini Space Station Rises, Oracle Slumps, Eli Lilly Rises on Experimental Shot Cutting Weight
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
